Acro Biomedical Co., Ltd.
ACBM· OTC
ACBMAcro Biomedical Co., Ltd.
Filed May 13, 2016 · 10-Q · 43 days after period end · 0001640334-16-001061
| Metric | Q2 2016 | Q2 2015 |
|---|---|---|
| Net Income | -$6.35K | -$29.00 |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Acro Biomedical Co., Ltd. · CIK 1622996 · Engraved from SEC EDGAR
ended Mar 31, 2016 · filed May 13, 2016 · 43 d after period end
